Roberts, Glore & Co’s Clorox CLX Stock Holding History

Roberts, Glore & Co’s Portfolio CLX Stock Details CLX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-1,506	Closed	-$263K	–	204
2021 Q4	$263K	Buy	1,506 +35	+2%	+$5.83K	0.07%	171
2021 Q3	$244K	Buy	+1,471	New	+$253K	0.07%	168

Other funds holding CLX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Roberts, Glore & Co's CLX Position: Q1 2022 in Review

Roberts, Glore & Co sold out of Clorox (CLX) in Q1 2022, closing a stake of 1,506 shares — an estimated $263K sold.

Roberts, Glore & Co first reported a position in CLX in Q3 2021 and held it in 2 quarters. The position peaked at $263K in Q4 2021. 1,095 funds tracked by Wall St. Rank hold CLX as of Q1 2022.

Roberts, Glore & Co reported no remaining Clorox position as of Q1 2022 after selling out during the quarter.
Roberts, Glore & Co sold 1,506 Clorox shares in Q1 2022, an estimated $263K.
Roberts, Glore & Co first reported a position in Clorox in Q3 2021 and held it in 2 quarters.
Roberts, Glore & Co's Clorox position peaked at $263K in Q4 2021.
1,095 funds tracked by Wall St. Rank held Clorox as of Q1 2022.

Based on Roberts, Glore & Co's 13F filing for Q1 2022, filed 2 May 2022.